Central nervous system blastomycosis diagnosed using the MVista® Blastomyces quantitative antigen enzyme immunoassay test on cerebrospinal fluid: A case report and review of the literature

Diagn Microbiol Infect Dis. 2018 Feb;90(2):102-104. doi: 10.1016/j.diagmicrobio.2017.10.015. Epub 2017 Oct 31.

Abstract

Blastomyces dermatitidis is a thermally dimorphic fungus that is capable of causing pulmonary and extra-pulmonary disease, including infections of the central nervous system (CNS). Diagnosis of CNS blastomycosis with non-invasive testing can be difficult, and a surgical biopsy may ultimately be required for microbiological and/or histopathological confirmation. A case of B. dermatitidis meningitis is presented where the diagnosis was made by testing cerebrospinal fluid (CSF) using the MVista® Blastomyces Quantitative Antigen Enzyme Immunoassay test. The utility of performing this test on CSF for diagnosis of CNS mass lesions/abscesses caused by B. dermatitidis in the absence of associated meningitis remains unclear. Cross reaction of the Blastomyces antigen test with other dimorphic fungi is a concern, necessitating that positive test results are interpreted in the context of the patient's exposure and travel history.

Keywords: Blastomyces antigen; Blastomycosis; Central nervous system.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antigens, Fungal / cerebrospinal fluid*
  • Blastomyces
  • Blastomycosis / cerebrospinal fluid
  • Blastomycosis / diagnosis*
  • Blastomycosis / microbiology
  • Central Nervous System Fungal Infections / cerebrospinal fluid
  • Central Nervous System Fungal Infections / diagnosis*
  • Central Nervous System Fungal Infections / microbiology
  • Humans
  • Immunoenzyme Techniques / methods*
  • Male

Substances

  • Antigens, Fungal